4//SEC Filing
NIFFENEGGER KATHI 4
Accession 0001144204-18-014750
CIK 0001540159other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 8:20 PM ET
Size
5.4 KB
Accession
0001144204-18-014750
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2018-03-12+35,000→ 35,000 totalExercise: $0.84Exp: 2025-03-12→ Common Shares (35,000 underlying)
Footnotes (1)
- [F1]Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 12, 2019 and as to the remaining one-third on September 12, 2019.
Documents
Issuer
Stellar Biotechnologies, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001620146
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 8:20 PM ET
- Size
- 5.4 KB